A unique opportunity to invest  in Australian early stage life sciences companies (drug discovery, medical technology and biotechnology), backed by industry specialists with expertise in translating early stage science to commercial outcomes.

Kobold Ventures identifies early stage opportunities that have clear IP positions with a higher likelihood of success in the clinic.

Kobold Ventures works actively with companies to enhance translation of their opportunities to commercial inflection points with program direction.

The team has over 100 years combined experience in the life sciences space in translation and commercialization of life sciences ventures.  The team is embedded in the Australian life sciences sector.